{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:55:42Z","timestamp":1776426942028,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010391","name":"Tokyo Women's Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010391","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>With regard to complications of portal vein (PV) and inferior vena cava (IVC) thrombosis in autosomal dominant polycystic kidney disease (ADPKD), several cases have been reported based on imaging findings. However, only one autopsy case has been described and no systematic analysis has been conducted to date. This retrospective study aimed to review autopsy cases from our department over the past 37\u00a0years to clarify the frequency and background factors of thrombosis formation in ADPKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Among 4001 autopsies performed at our institution from 1987 to 2023, 10 ADPKD cases were identified. We examined the presence of thrombus in these 10 cases and compared pleural effusion and ascites volumes, major organ weights, and clinicopathological factors between cases with thrombus and those without.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 10 ADPKD cases, thrombi were identified in four cases in which autopsies were performed relatively recently. These thrombi were distributed in the PV, IVC, and their branches. Compared to non-thrombotic cases, those with thrombi showed a statistically significant increase in kidney weight and tended to have a higher frequency of complications such as sepsis and severe aortic atherosclerosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study reports the first systematic autopsy-based investigation of PV and IVC thrombosis in ADPKD. Thrombosis was found at a high frequency of 40% and appears to have increased in recent years. Increased kidney weight was associated with thrombosis formation, and blood stasis due to compression by enlarged kidneys is considered the primary cause. Further case accumulation and elucidation of the pathophysiology involved are anticipated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10157-026-02825-w","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:52:03Z","timestamp":1770393123000},"page":"718-725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and clinicopathological analysis of portal vein and inferior vena cava thrombosis in autopsy cases of autosomal dominant polycystic kidney disease"],"prefix":"10.1007","volume":"30","author":[{"given":"Anna","family":"Shinozaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"2825_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-981-10-2041-4_2","volume":"933","author":"DY Kim","year":"2016","unstructured":"Kim DY, Park JH. Genetic mechanisms of ADPKD. Adv Exp Med Biol. 2016;933:13\u201322.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"2825_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cld.2022.01.009","volume":"26","author":"R Roediger","year":"2022","unstructured":"Roediger R, Dieterich D, Chanumolu P, Deshpande P. Polycystic kidney\/liver disease. Clin Liver Dis. 2022;26(2):229\u201343.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"2825_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1681\/ASN.2017050483","volume":"29","author":"E Cornec-Le Gall","year":"2018","unstructured":"Cornec-Le Gall E, Torres VE, Harris PC. Genetic complexity of autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol. 2018;29(1):13\u201323.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2825_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/MNH.0000000000000113","volume":"24","author":"A Alam","year":"2015","unstructured":"Alam A. Risk factors for progression in ADPKD. Curr Opin Nephrol Hypertens. 2015;24(3):290\u20134.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"10174","key":"2825_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393(10174):919\u201335.","journal-title":"Lancet"},{"issue":"1","key":"2825_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s13730-023-00795-6","volume":"13","author":"Y Tsuchida","year":"2024","unstructured":"Tsuchida Y, Tsubata Y, Nozawa R, Maruyama S, Ikarashi K, Saito N, et al. Fatal acute portal vein thrombosis associated with hepatic cysts in a patient with autosomal dominant polycystic kidney disease. CEN Case Rep. 2024;13(1):32\u20136.","journal-title":"CEN Case Rep"},{"issue":"3","key":"2825_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/0036933014567050","volume":"61","author":"R Tamburrini","year":"2016","unstructured":"Tamburrini R, Ahmed Z, van der Walt J, Goldsmith D. Sudden death of a patient with polycystic kidneys due to acute inferior vena cava thrombosis. Scott Med J. 2016;61(3):171\u20133.","journal-title":"Scott Med J"},{"issue":"5","key":"2825_CR8","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1681\/ASN.V551186","volume":"5","author":"VE Torres","year":"1994","unstructured":"Torres VE, Rastogi S, King BF, Stanson AW, Gross JB Jr, Nagorney DM. Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease. Soc Nephrol. 1994;5(5):1186\u201392.","journal-title":"Soc Nephrol"},{"issue":"1","key":"2825_CR9","first-page":"75","volume":"22","author":"R Perces","year":"2002","unstructured":"Perces R, Gil F, Costero O, Pobes A. Massive inferior vena cava thrombosis in a patient with autosomal dominant polycystic hepatorenal disease. Nefrologia. 2002;22(1):75\u20138.","journal-title":"Nefrologia"},{"issue":"3","key":"2825_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2169\/internalmedicine.43.209","volume":"43","author":"S Iguchi","year":"2004","unstructured":"Iguchi S, Kasai A, Kishimoto H, Suzuki K, Ito S, Ogawa Y, et al. Thrombosis in inferior vena cava (IVC) due to intra-cystic hemorrhage into a hepatic local cyst with autosomal dominant polycystic kidney disease (ADPKD). Intern Med. 2004;43(3):209\u201312.","journal-title":"Intern Med"},{"issue":"17","key":"2825_CR11","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.2169\/internalmedicine.49.3748","volume":"49","author":"T Maeda","year":"2010","unstructured":"Maeda T, Uchida Y, Oyamada K, Nakajima F. Thrombosis in inferior vena cava due to enlarged renal cysts in autosomal dominant polycystic kidney disease. Intern Med. 2010;49(17):1891\u20134.","journal-title":"Intern Med"},{"issue":"12","key":"2825_CR12","first-page":"PD24","volume":"10","author":"S Murthuraman","year":"2016","unstructured":"Murthuraman S, Ramamurthy A, Gopashetty M, Vijayshankar CS, Khakhar A. Supra hepatic inferior vena cava thrombosis-surgical challenges. J Clin Diagn Res. 2016;10(12):PD24\u20135.","journal-title":"J Clin Diagn Res"},{"issue":"33","key":"2825_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004597","volume":"95","author":"J Xie","year":"2016","unstructured":"Xie J, Zhang XB, Wang WZ, Li HZ. Case report of renal pelvis squamous cell carcinoma with tumor embolus in autosomal dominant polycystic kidney disease. Med (Baltimore). 2016;95(33):e4597.","journal-title":"Med (Baltimore)"},{"issue":"2","key":"2825_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjac012","volume":"2022","author":"JEZ Chan","year":"2022","unstructured":"Chan JEZ, Kuah Z, Bhattacharjya S, Olakkengil SA. Recurrent thromboses and major vessel compressions in autosomal dominant polycystic kidney disease. J Surg Case Rep. 2022;2022(2):rjac012.","journal-title":"J Surg Case Rep"},{"issue":"2","key":"2825_CR15","first-page":"138","volume":"41","author":"Y Okamura","year":"2024","unstructured":"Okamura Y, Yamamoto T, Masui K, Onizuka Y, Matsunaga H, Takayama K, et al. An autopsy case of autosomal dominant polycystic kidney disease associated with portal thrombosis. Jpn J Diagn Pathol. 2024;41(2):138\u201344.","journal-title":"Jpn J Diagn Pathol"},{"issue":"1","key":"2825_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jceh.2014.12.008","volume":"5","author":"YK Chawala","year":"2015","unstructured":"Chawala YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5(1):22\u201340.","journal-title":"J Clin Exp Hepatol"},{"issue":"35","key":"2825_CR17","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.3748\/wjg.v19.i35.5775","volume":"19","author":"B Abu-Wasel","year":"2013","unstructured":"Abu-Wasel B, Walsh C, Keough V, Molinari M. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol. 2013;19(35):5775\u201386.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2825_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/hep.29582","volume":"68","author":"L Barbier","year":"2018","unstructured":"Barbier L, Ronot M, Aussilhou CF, Francoz C, Vilgrain V, et al. Polycystic liver disease: hepatic venous outflow obstruction lesions of the noncystic parenchyma have major consequences. Hepatology. 2018;68(2):652\u201362.","journal-title":"Hepatology"},{"issue":"16","key":"2825_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168882","volume":"22","author":"K Moriyama","year":"2021","unstructured":"Moriyama K, Nishida O. Targeting cytokines, pathogen-associated molecular patterns and damage-associated molecular patterns in sepsis via blood purification. Int J Mol Sci. 2021;22(16):8882.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2825_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tcm.2015.12.001","volume":"26","author":"M Witkowski","year":"2016","unstructured":"Witkowski M, Landmesser U, Rauch U. Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc Med. 2016;26(4):297\u2013303.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"2825_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5551\/jat.12.1","volume":"12","author":"K Marutsuka","year":"2005","unstructured":"Marutsuka K, Hatakeyama K, Yamashita A, Asada Y. Role of thrombogenic factors in the development of atherosclerosis. J Atheroscler Thromb. 2005;12(1):1\u20138.","journal-title":"J Atheroscler Thromb"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02825-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02825-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02825-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:09:33Z","timestamp":1776424173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02825-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2825"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02825-w","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethics standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number 2024\u20130125) and with the 1964 Helsinki Declaration and its later amendments or comparable ethics standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Comprehensive consent for research on autopsy specimens was obtained from each patient\u2019s family at the time of autopsy.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}